Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients

October 3, 2020 updated by: Huang YuGuang, Peking Union Medical College Hospital

Effect of Pneumoperitoneum Pressure and the Extent of Neuromuscular Block on Renal Function in Patients With Diabetes Undergoing Laparoscopic Pelvic Surgery

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Deep neuromuscular block is defined as post tetanic count (PTC) 1-2, and low neuromuscular block is defined as train-of-four (TOF) twitch 1-2. The outcomes will be indicators for acute kidney injury and surgical condition.

Study Overview

Detailed Description

In this single center, double-blind, randomized controlled clinical trial, we will include 648 diabetes patients aged 18-70 undergoing laparoscopic pelvic tumor resection under general anesthesia. They will be randomized to the following four groups: high-pressure pneumoperitoneum (10mmHg)+ deep neuromuscular block group, high-pressure pneumoperitoneum (15mmHg)+moderate neuromuscular block group, low-pressure pneumoperitoneum + deep neuromuscular block group and low-pressure pneumoperitoneum+moderate neuromuscular block group. Neuromuscular block will be induced by rocuronium bolus and maintained by a continuous infusion of rocuronium. Deep neuromuscular block is defined as PTC 1-2, and low neuromuscular block is defined as train-of-four TOF twitch 1-2. The primary outcome will be serum Cystatin C level, and the secondary outcomes will be serum creatine level, urinary sediment, intraoperative urine output, duration of surgery, surgical space condition and occurrence bucking and body movement.

Study Type

Interventional

Enrollment (Anticipated)

648

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Aged 18-70;
  2. American Society of Anesthesiologist physical status (ASA) II-Ⅲ;
  3. Diagnosed of diabetes;
  4. Undergoing elective laparoscopic pelvic tumor resection under general anesthesia;
  5. Estimated duration of operation >2h;

Exclusion criteria:

  1. Not willing to participate in the study or not able to sign the informed consent;
  2. Diagnosed of other kidney diseases except diabetic nephropathy;
  3. Severe renal insufficiency defined as serum creatine level > 2 times the upper limit of normal, or urine output < 0.5ml/kg/h, or estimated glomerular filtration rate < 60ml/h;
  4. Severe liver, lung or heart dysfunction;
  5. Known or suspect neuromuscular disease;
  6. Use of drugs that may affect neuromuscular block monitoring;
  7. Severe diabetic neuropathy or other peripheral neuropathy;
  8. Known or suspect allergy to general anesthetics;
  9. Family history of malignant hyperthermia;
  10. Previous history of pelvic surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: high pressure + deep block
Intra-abdominal pressure will be set to 12-15 mmHg during the surgery. Deep neuromuscular block will be induced by rocuronium bolus 1 mg/kg, maintained by a continuous infusion of rocuronium (0.6mg/kg/h), and titrated towards post-tetanic count (PTC) 1-2.
High-pressure pneumoperitoneum is defined as intra-abdominal pressure 12-15 mmHg.
Deep neuromuscular block is defined as PTC 1-2.
Experimental: high pressure + moderate block
Intra-abdominal pressure will be set to 12-15 mmHg during the surgery. Moderate neuromuscular block will be induced by rocuronium bolus 0.6 mg/kg, maintained by a continuous infusion of rocuronium (0.3mg/kg/h), and titrated towards train-of-four (TOF) twitch 1-2.
High-pressure pneumoperitoneum is defined as intra-abdominal pressure 12-15 mmHg.
Moderate neuromuscular block is defined as TOF twitch 1-2.
Experimental: low pressure + deep block
Intra-abdominal pressure will be set to 7-10 mmHg during the surgery. Deep neuromuscular block will be induced by rocuronium bolus 1 mg/kg, maintained by a continuous infusion of rocuronium (0.6mg/kg/h), and titrated towards PTC 1-2.
Deep neuromuscular block is defined as PTC 1-2.
Low-pressure pneumoperitoneum is defined as intra-abdominal pressure 7-10 mmHg.
Experimental: low pressure + moderate block
Intra-abdominal pressure will be set to 7-10 mmHg. Moderate neuromuscular block will be induced by rocuronium bolus 0.6 mg/kg, maintained by a continuous infusion of rocuronium (0.3mg/kg/h), and titrated towards TOF twitch 1-2.
Deep neuromuscular block is defined as PTC 1-2.
Moderate neuromuscular block is defined as TOF twitch 1-2.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum cystatin C (CysC) level
Time Frame: 30 minutes before pneumoperitoneum insufflation
CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR).
30 minutes before pneumoperitoneum insufflation
Serum cystatin C (CysC) level
Time Frame: 30 minutes after pneumoperitoneum deflatation
CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR).
30 minutes after pneumoperitoneum deflatation
Serum cystatin C (CysC) level
Time Frame: Postoperative 24 hours
CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR).
Postoperative 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum creatine level
Time Frame: 30 minutes before pneumoperitoneum insufflation
Creatine is also an indicator for kidney injury
30 minutes before pneumoperitoneum insufflation
Serum creatine level
Time Frame: 30 minutes after pneumoperitoneum deflatation
Creatine is also an indicator for kidney injury
30 minutes after pneumoperitoneum deflatation
Serum creatine level
Time Frame: Postoperative 24 hours
Creatine is also an indicator for kidney injury
Postoperative 24 hours
The volume of intraoperative urine output
Time Frame: At the end of the surgery
A urine tube will be inserted just before the surgery, so the urine can be drained into a bag. The volume of urine in the bag at the end of the surgery will be the volume of intraoperative urine output.
At the end of the surgery
The presence of isomorphic or dysmorphic erythrocyte in urinary sediment
Time Frame: Postoperative day 1
Erythrocyte in urinary sediment is also an indicator of renal injury.
Postoperative day 1
Duration of surgery
Time Frame: Intraoperative
Duration of surgery is an indicator for procedure difficulty
Intraoperative
Leiden-surgical rating scale
Time Frame: The moment when trocars are introduced into pelvic cavity, and then every 15 minutes till the end of surgery.
We will use Leiden surgical rating scale (Martini et al.) to assess surgical condition. It is a 5-point scale, the minimum and maximum values are 1 and 5, respectively. Higher score indicates better surgical condition.
The moment when trocars are introduced into pelvic cavity, and then every 15 minutes till the end of surgery.
The number of bucking and body movement during the surgery
Time Frame: Intraoperative
The occurrence of bucking or body movement is an indicator for the sufficiency of muscle relaxant.
Intraoperative
Renal tissue oxygen saturation
Time Frame: Intraoperative
Renal oxygen saturation is an indicator for renal tissue oxygenation.
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuguang Huang, M.D., Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2020

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

February 2, 2020

First Submitted That Met QC Criteria

February 5, 2020

First Posted (Actual)

February 6, 2020

Study Record Updates

Last Update Posted (Actual)

October 6, 2020

Last Update Submitted That Met QC Criteria

October 3, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Clinical Trials on high pressure

3
Subscribe